Core Insights - Outset Medical, Inc. is presenting at the 2025 Stifel Healthcare conference on November 12, 2025, at 10:40 a.m. Eastern time [1] - The company is focused on transforming the dialysis experience with its innovative Tablo Hemodialysis System, which is FDA-cleared for use from hospital to home [3] Company Overview - Outset Medical is a medical technology company that aims to reduce the cost and complexity of dialysis through its first-of-its-kind technology [3] - The Tablo Hemodialysis System is trusted by over 1,000 U.S. healthcare facilities and has facilitated millions of treatments delivered by thousands of nurses [3] - The system integrates water purification and on-demand dialysate production, connecting seamlessly with Electronic Medical Record systems and a proprietary data analytics platform [3] - Outset empowers healthcare providers to develop in-house dialysis programs, leading to improved operational, clinical, and financial outcomes [3] - The company is committed to redefining kidney care through innovation and a focus on enhancing the lives of patients and healthcare professionals [3]

Company Overview - Outset Medical, Inc. is a medical technology company focused on transforming the dialysis experience with innovative technology [3] - The company has developed the Tablo Hemodialysis System, which is FDA-cleared for use in various healthcare settings, from hospitals to home [3] - Tablo integrates water purification and on-demand dialysate production into a single system, enhancing operational efficiency and patient care [3] Market Presence - The Tablo system is trusted by over 1,000 healthcare facilities in the U.S. and has facilitated millions of treatments administered by thousands of nurses [3] - Outset Medical aims to empower healthcare providers to establish in-house dialysis programs, leading to improved operational, clinical, and financial outcomes [3] Upcoming Events - Management will present at the 23rd annual Morgan Stanley Global Healthcare Conference on September 10, 2025, at 7 a.m. Eastern time [1] - A live and archived webcast of the presentation will be available on the company's investor relations website [2]

Core Viewpoint - Outset Medical, Inc. is set to release its financial results for Q1 2025 on May 7, 2025, highlighting its innovative approach to dialysis technology [1]. Company Overview - Outset Medical is a medical technology company focused on reducing the cost and complexity of dialysis through its pioneering technology [4]. - The Tablo Hemodialysis System, which is FDA cleared for use in various settings, represents a significant advancement in dialysis technology, transforming the patient experience and simplifying operations for providers [4]. - Tablo functions as a comprehensive solution for dialysis care, enabling treatment to be delivered anytime and anywhere, supported by features such as water purification, on-demand dialysate production, and two-way wireless data transmission [4]. Conference Call Details - A conference call will be held on May 7, 2025, at 2:00 p.m. Pacific time (5:00 p.m. Eastern time) to discuss the financial and operational results [2][3]. - Participants can register online to receive dial-in numbers and a unique pin for the call, with a recommendation to register at least 15 minutes prior to the start [3].